The purpose of the WellKiwis Infant study is to follow children from birth to age seven, watching closely how their first exposure to the flu or the flu vaccine influences their ongoing immunity. This will provide information to enable our scientists and researchers to make more effective and longer lasting flu vaccines for our future populations.
The aim of this research study is to help us answer the following questions to fill in the global knbowledge gaps:
WellKiwis Infant- Yearly Study Activities [PDF, 606 KB]
WellKiwis Infant- Participant Information Sheet [PDF, 4.1 MB]
WellKiwis Infant- FAQs [PDF, 912 KB]